Advantage commences Feasibility Study and continues to strengthen its project team in Argentina

V.AAL, Advantage Lithium, lithium, Argentina, David Sidoo

dvantage Lithium Corp. (the “Company” or “Advantage Lithium”) (TSX Venture: AAL) (OTCQX: AVLIF) is pleased to announce that it has engaged GHD, Chile S.A. to complete early engineering geared towards the completion of a Feasibility Study (FS) to be completed by June 2019 on its flagship Cauchari Project in Jujuy, Argentina. This follows positive PEA outcomes and continued positive results in the phase III resource conversion program, on schedule to support the Feasibility Study delivery on time. The Feasibility Study will provide an appropriate engineering design to produce a Class 3 cost estimate (consistent with AACE principles) to build a standalone plant for 20 Ktpa of final Lithium product. A report on this work will be prepared in accordance with NI43-101 standards of disclosure and is scheduled for completion in June 2019. read more

MGX Minerals Reports High-Grade Gold Mineralization at Depth Fran Gold Project, British Columbia; Winter Drilling Underway

CSE:XMG, MGX Minerals, lithium,

MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / FKT: 1MG / OTCQB: MGXMF) is pleased to report additional drill results from its Fall 2018 drill program at the Fran Gold Property (“Fran” or the “Property”) in British Columbia, 30 kilometers southwest of the Mount Milligan Gold-Copper mine. read more

Goldplay Completes Private Placement

V.GPLY, Goldplay Exploration, gold
Cision

Goldplay Exploration Ltd. (TSXV: GPLY, OTCQB: GLYXF) (“Goldplay” or the “Company”), is pleased to announce that the Company has closed the final tranche of its non-brokered private placement (the “Offering“) previously announced on November 19, 2018 and has issued 1,244,166 units for gross proceeds of $273,716.52.  Total gross proceeds raised under all tranches of this offering was $1,499,960. read more

FSD Pharma Featured in CannaInvestor Magazine December Issue

C.HUGE, FSD Pharma, cannabis, pot

FSD Pharma Inc. (“FSD Pharma”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) today announced that it is the featured company in the CannaInvestor Magazine December 2018 Issue. CannaInvestor Magazine is the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and the financial media. The digital version of the magazine is accessible and free to all subscribers who enter their email address. FSD Pharma’s cover feature can be found by clicking on this link https://joom.ag/0j5a or visiting CannaInvestor Magazine’s website www.cannainvestormag.ca. read more